ENTA
Price
$7.64
Change
+$0.41 (+5.67%)
Updated
Jul 18, 03:58 PM (EDT)
Capitalization
154.55M
24 days until earnings call
PLRX
Price
$1.43
Change
+$0.01 (+0.70%)
Updated
Jul 18, 02:06 PM (EDT)
Capitalization
87.17M
24 days until earnings call
Interact to see
Advertisement

ENTA vs PLRX

Header iconENTA vs PLRX Comparison
Open Charts ENTA vs PLRXBanner chart's image
Enanta Pharmaceuticals
Price$7.64
Change+$0.41 (+5.67%)
Volume$7.11K
Capitalization154.55M
Pliant Therapeutics
Price$1.43
Change+$0.01 (+0.70%)
Volume$100
Capitalization87.17M
ENTA vs PLRX Comparison Chart in %
Loading...
ENTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ENTA vs. PLRX commentary
Jul 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ENTA is a Hold and PLRX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 18, 2025
Stock price -- (ENTA: $7.23 vs. PLRX: $1.42)
Brand notoriety: ENTA and PLRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ENTA: 71% vs. PLRX: 86%
Market capitalization -- ENTA: $154.55M vs. PLRX: $87.17M
ENTA [@Biotechnology] is valued at $154.55M. PLRX’s [@Biotechnology] market capitalization is $87.17M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.62B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ENTA’s FA Score shows that 1 FA rating(s) are green whilePLRX’s FA Score has 0 green FA rating(s).

  • ENTA’s FA Score: 1 green, 4 red.
  • PLRX’s FA Score: 0 green, 5 red.
According to our system of comparison, ENTA is a better buy in the long-term than PLRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ENTA’s TA Score shows that 4 TA indicator(s) are bullish while PLRX’s TA Score has 5 bullish TA indicator(s).

  • ENTA’s TA Score: 4 bullish, 5 bearish.
  • PLRX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, PLRX is a better buy in the short-term than ENTA.

Price Growth

ENTA (@Biotechnology) experienced а +3.58% price change this week, while PLRX (@Biotechnology) price change was +1.43% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.73%. For the same industry, the average monthly price growth was +13.28%, and the average quarterly price growth was +34.98%.

Reported Earning Dates

ENTA is expected to report earnings on Nov 24, 2025.

PLRX is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+2.73% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ENTA($155M) has a higher market cap than PLRX($87.2M). ENTA YTD gains are higher at: 25.739 vs. PLRX (-89.218). ENTA has higher annual earnings (EBITDA): -87.12M vs. PLRX (-214.08M). PLRX has more cash in the bank: 306M vs. ENTA (193M). ENTA (58.7M) and PLRX (60.2M) have identical debt. ENTA has higher revenues than PLRX: ENTA (64.5M) vs PLRX (0).
ENTAPLRXENTA / PLRX
Capitalization155M87.2M178%
EBITDA-87.12M-214.08M41%
Gain YTD25.739-89.218-29%
P/E RatioN/AN/A-
Revenue64.5M0-
Total Cash193M306M63%
Total Debt58.7M60.2M98%
FUNDAMENTALS RATINGS
ENTA: Fundamental Ratings
ENTA
OUTLOOK RATING
1..100
59
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
49
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ENTAPLRX
RSI
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
68%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
62%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
75%
MACD
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
75%
Advances
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 5 days ago
76%
Declines
ODDS (%)
Bearish Trend 8 days ago
84%
Bearish Trend 3 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
53%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
ENTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BULT0.060.01
+13.73%
BULLET BLOCKCHAIN INC.
NDRBF4.66N/A
N/A
Nibe Industrier AB
PGINF4.16N/A
N/A
Prestige International Inc.
VDKB1.00N/A
N/A
Vodka Brands Corp
ITVPY10.67-0.02
-0.18%
ITV Plc.

PLRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PLRX has been loosely correlated with LXRX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if PLRX jumps, then LXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLRX
1D Price
Change %
PLRX100%
+5.97%
LXRX - PLRX
41%
Loosely correlated
+4.65%
OCUL - PLRX
41%
Loosely correlated
+1.16%
ITRM - PLRX
41%
Loosely correlated
+1.03%
SRRK - PLRX
41%
Loosely correlated
+4.16%
FHTX - PLRX
40%
Loosely correlated
+3.74%
More